Title: Economic and Other Contextual Determinants of the Desirability and Viability of Intermittent Prevent
1Economic and Other Contextual Determinants of the
Desirability and Viability of Intermittent
Preventive Treatment of Malaria during Pregnancy
in Tanzania Godfrey M. Mubyazi., Ø.Olsen,.,
K.S. Hansen., I.C. Bygbjerg., P.Magnussen., J.
Byskov., L.E.G Mboera Paul Bloch
- What literature says about Potential Barriers to
ANC service Delivery and Use in poor countries
(ctd..) - Travel barriers to and from health care
facilities - Client drug demand-driven health workers
prescription and drug dispensing - Understaffing and shortage of working tools in
health facilities - Hard working conditions demoralizing health
workers - Trust in traditional health practices e.g.
T-birth attendants - Late attendance to ANC clinics compromising
completion rate of drug dosage (e.g. for IPTp) - Fear of being tested for HIV by attending ANC
clinics - Perceived poor quality of care at health
facilities by pregnant women and the society
around them - Rationale of the present research on malaria
IPTp in TZ - According to WHO, interventions deemed
efficacious within clinical trials may not be
feasible in real world contexts. Other experts
contend that non-biomedical determinants of the
malaria epidemiology have received little
attention in malaria control programmes although
they are imperative to complement biomedical
evidence. Conceptually, the present PhD study
focuses on economic factors in a way they may not
be acting in isolation of social, geographical
and health system contexts influencing the
behaviour of antimalarial service users and
providers. - Study Methods The PhD study is exploratory
analytical in design. It applies qualitative and
quantitative techniques - (i) Separate
semistructured interview tools targeting pregnant
women while leaving public/other ANC clinics
after service and health staff working at such
clinics (ii) Focus group discussions with
mothers/caretakers of infants aged 1-2 years and
pregnant women (both groups traced at community
level) and with members of district health
management team (iii) Individual indepth
interviews with financial accounts officers and
planners and national level policymakers and
malaria control managers (iv) documentary review
on malaria related budget/accounts and
IPTp-policy aspects at health facility and
district level (v) researchers observation of
ANC service environments. - Results Findings from the pilot study are being
analysed while the actual study will follow the
MIM Conference in later in this November. - Acknowledgements GMP for Funding the PhD study
Godfreys participation at the MIM Conference
Carol Aldous, Heather Naylor GMP Prof. B
Greenwoods Office in London at large
CEEMI-NIMR-TZ for communication and coordination
MIM Conference Organizers for invitation Dr P
Bloch colleagues for supervising Godfreys PhD
DBL-IHRD Copenhagen University for registering
Godfreys PhD study. Dr Catherine Goodman of
LSHTM for suggesting some literature for review
for Godfreys PhD study. MoH/MRCC-TZ for study
Ethics Clearance.
The Global Malaria Epidemiological
Situation Globally malaria causes about 500
million cases and 1-2 million deaths each year,
pregnant women and children under five years
being most vulnerable. Of all the cases,
Sub-Saharan Africa (SSA) contributes about 90.
Reports by WHO and other malaria exerts show that
malaria during pregnancy may cause impaired fatal
growth, miscarriage, premature birth,
inter-uterine growth restrictions, cerebral
problems and low birth-weight, all of which exist
in endemic countries. Malaria and its burden
on socio-economic development Evidence from a
number of studies supports the hypothetical
contention that in SSA the cost of time,
financial, and other materials for preventing and
treating malaria is enormous, and malaria plays a
significant role in the poverty cycle
concurrently with other problems related to HIV
and TB. In TZ malaria consumes about 3.4 of the
GDP and about 120 billion shillings per year.
Demographic and Health Survey 2004-2005 and other
literature indicates malaria as one of the
leading causes of maternal morbidity and
mortality in TZ. Intermittent Preventive
Treatment of Malaria (IPTm) in TZ Use of SP for
IPT in pregnancy (IPTp) has shown to be safe,
efficacious and cost-effective in countries close
to TZ. In line with WHOs advice, the Government
recommended IPT as part of focused Antenatal Care
(ANC) package. The national guidelines require
health workers at ANC clinics to administer
through the Direct Observation Therapy system a
single dose of 3 tablets of sulfadoxine-pyrimetham
ine (SP) to each pregnant woman contacting ANC
clinics during the 2nd and early 3rd trimesters.
Current critical debate about the use of SP for
IPTm Increasing evidence on rapid P.falciparum
resistance to SP in East and Central Africa has
opened research and policy debate about the
usefulness of SP. Sceptics also argue that
knowledge of the benefits of IPT may be low in
SSA settings where health information is
imperfectly accessible. Meanwhile, with SSA
countries recommending artemisinin-based
combination therapies (ACT), scientists doubt
about the feasibility of ACT in terms of cost and
compliance with the drug among service providers
and drug users if it is recommended for IPT (b)
its possible influence on health staff attitudes
and behaviours in relation to SP that may remain
the drug for IPT after ACT has been recommended
as the 1st line for uncomplicated malaria. PhD
study supported by The Gates Malaria Partnership
(GMP) in Tanzania A study is underway towards
analysing cost and quality of ANC related- and
other contextual determinants of the desirability
and viability of of IPTp in two district settings
located in different regions. What literature
says about Potential Barriers to ANC service
Delivery and Use in poor countries User fees in
countries health system where exemption
mechanisms poorly implemented Financial poverty
among women from poor socio-economic and male
dominated households/families